Interleukin-1β and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: Correlation to bone mineral density and susceptibility to osteoporosis

Maturitas

Volumn 44, Issue 1, 2003, Pages 49-54

  Chen, Huey Yi ^a,b   Chen, Wen Chi ^a   Wu, Mei Chen ^a   Tsai, Fuu Jen ^a   Lin, Cheng Chieh ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Bone mineral density; Interleukin 1 receptor antagonist gene polymorphism; Interleukin 1 gene polymorphism; Osteoporosis; Polymerase chain reaction; Postmenopausal women

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; SIALOGLYCOPROTEIN;

ADULT; ALLELE; ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM INTAKE; CORRELATION ANALYSIS; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; EXON; FEMALE; FEMUR NECK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; PROMOTER REGION; STATISTICAL ANALYSIS; GENETIC POLYMORPHISM; GENETICS; LUMBAR VERTEBRA; MIDDLE AGED; POSTMENOPAUSE;

BONE DENSITY; FEMALE; FEMUR NECK; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE; SIALOGLYCOPROTEINS;

EID: 0037472912     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00313-4     Document Type: Article

References (15)

1. Keen R.W., Kelly P.J. Genetic factors in osteoporosis: what are the implications for prevention and treatment? Drug Aging. 11:1997;333-337.
2. Pocock N.A., Eisman J.A., Hopper J.L., et al. Genetic determinants of bone mass in adults. J. Clin. Invest. 80:1987;706-710.
3. Kelly P.J., Nguyen T.V., Hopper J.L., et al. Changes in axial bone density with age: a twin study. J. Bone Miner. Res. 8:1993;11-17.
4. Ralston S.H. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J. Bone Miner. Res. 9:1994;883-890.
5. Steinkasserer A., Spurr N.K., Cox S., et al. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1α and IL-1β loci. Genomics. 13:1992;654-657.
6. Langdahl B.L., Løkke E., Carstens M., et al. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1β gene. J. Bone Miner. Res. 15:2000;402-414.
7. Di Giovine F.S., Takhsh E., Blakemore A.I.F., et al. Single base polymorphism at -511 in the human interleukin-1β gene. Hum. Mol. Genet. 1:1992;450.
8. Pociot F., Molvig J., Wogensen L., et al. A TagI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secrection in vitro. Eur. J. Clin. Invest. 22:1992;396-402.
9. Tarlow J.K., Blakemore A.I.F., Lennard A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 base pair tandem repeat. Hum. Genet. 91:1993;403-404.
10. Pun K.K., Wong F.H., Lok T. Rapid postmenopausal loss of total body and regional bone mass in normal Southern Chinese females in Hong Kong. Osteoporosis Int. 1:1991;87-94.
11. Cantagrel A., Navaux F., Loubet-Lescoulie P., et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 42:1999;1093-1100.
12. Report of a World Health Organization Study Group: assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva, WHO, 1994.
13. Tsai K.S., Huang K.M., Chieng P.U., Su C.T. Bone mineral density of normal Chinese women in Taiwan. Calcif. Tissue Int. 48:1991;161-166.
14. Reginster J.Y. Calcitonin for prevention and treatment of osteoporosis. Am. J. Med. 95:1993;44-47.
15. Keen R.W., Woodford-Richens K.L., Lanchbury J.S., et al. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone. 23:1998;367-371.